FLUEQUIN, injection suspension for horses

Homepage Products Veterinary products FLUEQUIN, injection suspension for horses

Composition - 1 ml:

Active substances:

• Virus influensis A/Equi 1/Praha 56 inactivated, min. 160 HAU
• Virus influensis A/Equi 2/Morava 95 (European type) inactivated, min. 320 HAU
• Virus influensis A/Equi 2/Brno 97 (American type) inactivated, min. 320 HAU

Adjuvant: Aluminium hydroxide hydrated  for adsorption  0,2 ml                               

Excipients: Thiomersal 0.1 mg, Phosphate buffered saline solution ad 1 ml

Indication:

Preventive vaccination of horses against influenza.

Onset of immunity: Solid immunity starts 21 days following revaccination.

Duration of immunity: 6 months after primary vaccination course.

Contraindications:

Only healthy animals should be vaccinated.

It is not recommended to vaccinate sick animals.

Adcerse reactions:

Not known.

Target species:

Horse – Equus caballus

Dosage:

1 ml deep intramuscularly.

The first, basic vaccination takes place at the age of 3 to 6 months and revaccination is made 4 to 6 weeks later.

Further revaccinations take place at 6 to 12-month intervals depending on the infection situation.

Revaccinate pregnant mares in the last trimester of pregnancy, no later than one month before the planned delivery.

Note: In the case of foals born from mares demonstrably vaccinated before the delivery we recommend to vaccinate the foals at the age of 6 months due to the colostral immunity.

Advice on correct administration:  

Before use shake. Only healthy animals should be vaccinated.

No information is available on the safety and efficacy of this vaccine when used with any other  veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

Can be used during pregnancy and lactation. this veterinary medicinal product must not be mixed with other veterinary medicinal products.

Special storage precautions:

At a dry and dark place, at temperature between 2 and 8 °C. Long-term exposition of the vaccine to temperatures above 8 °C should be avoided.

Special warnings:  

Only healthy animals should be vaccinated. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.

Shelf life:

36 months, after the first opening of several doses: 12 hours.

Package:

 2 x 1 dose, 10 x 1 dose.

Not all pack sizes may be marketed.